Form 4: AMN Healthcare Legal Officer's Stock Vesting

AMN Healthcare's Chief Legal Officer, Whitney M. Laughlin, reported the vesting of 4,976 Restricted Stock Units and the subsequent sale of 1,212 shares for tax purposes.

Summary

• Whitney M. Laughlin, Chief Legal Officer of AMN Healthcare Services Inc., reported transactions on October 15, 2025.
• Acquired 4,976 shares of Common Stock upon the vesting of Restricted Stock Units (RSUs).
• Disposed of 1,212 shares of Common Stock at a price of $20.69 per share to cover tax obligations related to the RSU vesting.
• Beneficial ownership of Common Stock following these transactions is 20,496 shares.
• The transactions were executed pursuant to a Rule 10b5-1(c) plan.
• The Restricted Stock Units were granted on October 15, 2024, under the AMN Healthcare 2017 Equity Plan and vest in two tranches on the first and second anniversaries of the grant date.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the vesting of Restricted Stock Units and subsequent tax-related share withholding, which is a standard event and does not indicate significant positive or negative sentiment regarding the company's performance or outlook.

Positives

• The vesting of Restricted Stock Units indicates the execution of a long-term incentive compensation plan for a key executive.

Negatives

• A portion of shares (1,212) was sold to cover tax liabilities, which reduces the executive's direct beneficial ownership.

Future Outlook

The Restricted Stock Units granted on October 15, 2024, vest in two tranches on the first and second anniversaries of the grant date, implying another vesting event for the remaining tranche around October 15, 2026.

Industry Context

This Form 4 reports a routine insider transaction, common across all industries for executives receiving equity compensation. It does not provide specific insights into broader industry trends for healthcare staffing.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine compensation event for an executive.

Next Steps

• The remaining tranche of the Restricted Stock Units granted on October 15, 2024, is expected to vest on October 15, 2026.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction involving the vesting of Restricted Stock Units and the subsequent sale of shares for tax purposes. Such transactions are standard for executive compensation and do not provide new fundamental information to warrant a change in investment recommendation.

Keywords

AMN Healthcare, Form 4, Insider Transaction, Stock Vesting, Restricted Stock Units, Whitney M. Laughlin, Chief Legal Officer, 10b5-1 plan